Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guus F Rimmelzwaan

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Human Vaccines & Immunotherapeutics|March 16, 2012
Developing vaccines against virus infections: between hope and fearGuus F Rimmelzwaan
Expert Review of Vaccines|April 8, 2009
Candidate influenza vaccines based on recombinant modified vaccinia virus AnkaraGuus F Rimmelzwaan, Gerd Sutter
Current Opinion in Virology|July 23, 2013
Virus infections: T cells come to the rescueKatherine Kedzierska, Guus F Rimmelzwaan
Pathogens (Basel, Switzerland)|June 19, 2020
Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?Lucas Wilken, Guus F Rimmelzwaan
Vaccine|February 21, 2009
Correlates of protection: novel generations of influenza vaccinesGuus F Rimmelzwaan, Janet E McElhaney
Virus Research|June 6, 2013
Immune responses to infection with H5N1 influenza virusGuus F Rimmelzwaan, Jacqueline M Katz
Current Opinion in Virology|March 11, 2017
Editorial overview: Viral immunology: Dealing with bad newsJonathan W Yewdell, Guus F Rimmelzwaan
Viruses|February 23, 2019
Influenza Virus Infections and Cellular KinasesRobert Meineke, Guus F Rimmelzwaan, Husni Elbahesh
Human Vaccines & Immunotherapeutics|July 26, 2016
Viral vector-based influenza vaccinesRory D de Vries, Guus F Rimmelzwaan
Current Opinion in Immunology|May 8, 2018
Influenza vaccines: 'tailor-made' or 'one fits all'Giulietta Saletti, Thomas Gerlach, Guus F Rimmelzwaan
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Human Vaccines & Immunotherapeutics|March 16, 2012
Developing vaccines against virus infections: between hope and fearGuus F Rimmelzwaan
Expert Review of Vaccines|April 8, 2009
Candidate influenza vaccines based on recombinant modified vaccinia virus AnkaraGuus F Rimmelzwaan, Gerd Sutter
Current Opinion in Virology|July 23, 2013
Virus infections: T cells come to the rescueKatherine Kedzierska, Guus F Rimmelzwaan
Pathogens (Basel, Switzerland)|June 19, 2020
Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?Lucas Wilken, Guus F Rimmelzwaan
Vaccine|February 21, 2009
Correlates of protection: novel generations of influenza vaccinesGuus F Rimmelzwaan, Janet E McElhaney
Virus Research|June 6, 2013
Immune responses to infection with H5N1 influenza virusGuus F Rimmelzwaan, Jacqueline M Katz
Current Opinion in Virology|March 11, 2017
Editorial overview: Viral immunology: Dealing with bad newsJonathan W Yewdell, Guus F Rimmelzwaan
Viruses|February 23, 2019
Influenza Virus Infections and Cellular KinasesRobert Meineke, Guus F Rimmelzwaan, Husni Elbahesh
Human Vaccines & Immunotherapeutics|July 26, 2016
Viral vector-based influenza vaccinesRory D de Vries, Guus F Rimmelzwaan
Current Opinion in Immunology|May 8, 2018
Influenza vaccines: 'tailor-made' or 'one fits all'Giulietta Saletti, Thomas Gerlach, Guus F Rimmelzwaan
Pageof 24